| |
Latest 10 SEC filings (by transaction date) for SILK within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 7/24 | Mar 5/24 | Ballinger Kevin J. | Direct Ownership | Common Stock | P - Open market or private purchase | 11,700 | $16.99 |
Mar 5/24 | Mar 5/24 | Buchanan Lucas W. | Direct Ownership | Common Stock | S - Open market or private sale | -9,877 | $17.17 |
Mar 5/24 | Mar 5/24 | Ruedy Richard | Direct Ownership | Common Stock | S - Open market or private sale | -3,800 | $17.17 |
Mar 5/24 | Mar 5/24 | Davis Andrew S. | Direct Ownership | Common Stock | S - Open market or private sale | -5,481 | $17.17 |
Mar 5/24 | Mar 5/24 | Jones Marie L. | Direct Ownership | Common Stock | S - Open market or private sale | -2,602 | $17.17 |
Mar 5/24 | Mar 5/24 | Klemz Kevin M | Direct Ownership | Common Stock | S - Open market or private sale | -2,497 | $17.17 |
Mar 5/24 | Mar 1/24 | Buchanan Lucas W. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 74,954 | |
Mar 5/24 | Mar 1/24 | Davis Andrew S. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 62,201 | |
Mar 5/24 | Mar 1/24 | Jones Marie L. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 24,555 | |
Mar 5/24 | Mar 1/24 | McKhann Chas | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 110,313 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for SILK within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 7/24 | Mar 5/24 | Ballinger Kevin J. | Direct Ownership | Common Stock | P - Open market or private purchase | 11,700 | $16.99 |
Mar 5/24 | Mar 5/24 | Buchanan Lucas W. | Direct Ownership | Common Stock | S - Open market or private sale | -9,877 | $17.17 |
Mar 5/24 | Mar 1/24 | Buchanan Lucas W. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 74,954 | |
Mar 5/24 | Mar 5/24 | Ruedy Richard | Direct Ownership | Common Stock | S - Open market or private sale | -3,800 | $17.17 |
Mar 5/24 | Mar 5/24 | Davis Andrew S. | Direct Ownership | Common Stock | S - Open market or private sale | -5,481 | $17.17 |
Mar 5/24 | Mar 1/24 | Davis Andrew S. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 62,201 | |
Mar 5/24 | Mar 5/24 | Jones Marie L. | Direct Ownership | Common Stock | S - Open market or private sale | -2,602 | $17.17 |
Mar 5/24 | Mar 1/24 | Jones Marie L. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 24,555 | |
Mar 5/24 | Mar 1/24 | McKhann Chas | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 110,313 | |
Mar 5/24 | Mar 5/24 | Klemz Kevin M | Direct Ownership | Common Stock | S - Open market or private sale | -2,497 | $17.17 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cencora (N:COR) |
DexCom (OQ:DXCM) |
West Pharmaceutical Servi (N:WST) |